- Home
- OMER vs NGVC Comparison
OMER vs NGVC Comparison
Compare OMER & NGVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMER
- NGVC
- Stock Information
- Founded
- OMER 1994
- NGVC 1955
- Country
- OMER United States
- NGVC United States
- Employees
- OMER N/A
- NGVC N/A
- Industry
- OMER Biotechnology: Pharmaceutical Preparations
- NGVC Food Chains
- Sector
- OMER Health Care
- NGVC Consumer Staples
- Exchange
- OMER Nasdaq
- NGVC Nasdaq
- Market Cap
- OMER 667.0M
- NGVC 770.2M
- IPO Year
- OMER 2009
- NGVC 2012
- Fundamental
- Price
- OMER $7.88
- NGVC $40.63
- Analyst Decision
- OMER Buy
- NGVC
- Analyst Count
- OMER 3
- NGVC 0
- Target Price
- OMER $9.00
- NGVC N/A
- AVG Volume (30 Days)
- OMER 1.0M
- NGVC 145.5K
- Earning Date
- OMER 11-13-2024
- NGVC 02-06-2025
- Dividend Yield
- OMER N/A
- NGVC 1.02%
- EPS Growth
- OMER N/A
- NGVC 44.12
- EPS
- OMER N/A
- NGVC 1.47
- Revenue
- OMER N/A
- NGVC $1,241,585,000.00
- Revenue This Year
- OMER N/A
- NGVC $1.32
- Revenue Next Year
- OMER N/A
- NGVC N/A
- P/E Ratio
- OMER N/A
- NGVC $28.25
- Revenue Growth
- OMER N/A
- NGVC 8.86
- 52 Week Low
- OMER $2.61
- NGVC $14.31
- 52 Week High
- OMER $12.65
- NGVC $47.57
- Technical
- Relative Strength Index (RSI)
- OMER 45.47
- NGVC 51.93
- Support Level
- OMER $7.33
- NGVC $42.11
- Resistance Level
- OMER $12.65
- NGVC $45.04
- Average True Range (ATR)
- OMER 1.06
- NGVC 1.71
- MACD
- OMER -0.63
- NGVC -0.91
- Stochastic Oscillator
- OMER 10.34
- NGVC 3.48
About OMER Omeros Corporation
Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The lead drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.
About NGVC Natural Grocers by Vitamin Cottage Inc.
Natural Grocers by Vitamin Cottage Inc operates natural and organic grocery and dietary supplement stores. It offers the following product categories, natural and organic food, dietary supplements, natural body care, household, pet care products, books and handouts. The company generates the majority of its revenue from grocery products and dietary supplements and rest from other products.